Swiss drug maker Novartis posts Q4 profit drop

Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit.

The Basel, Switzerland-based company said Tuesday that fourth quarter net income came in at $1.49 billion, down from $2 billion in the same quarter the year before excluding its blood-transfusion diagnostics unit, which it sold in 2013. Novartis took a one-time charge of $1.1 billion in the quarter connected to the sale of its flu vaccine business.

Year-end profit rose to $10.3 billion in 2014, a 12 percent increase over 2013's $9.6 billion excluding the diagnostics unit.

CEO Joseph Jimenez said in 2014 Novartis "delivered solid sales growth with margin expansion, strengthened innovation and advanced our quality and productivity."

© 2015 The Associated Press. All rights reserved.

Citation: Swiss drug maker Novartis posts Q4 profit drop (2015, January 27) retrieved 19 March 2024 from https://medicalxpress.com/news/2015-01-swiss-drug-maker-novartis-q4.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Novartis Q4 net profit rises to $2.0 billion

5 shares

Feedback to editors